Treatment of Urinary Bilharziasis in a Small Focus with Sodium Antimony Dimercaptosuccinate (Astiban®)

F. ArfaaInstitute of Public Health Research, Teheran University, Teheran, Iran

Search for other papers by F. Arfaa in
Current site
Google Scholar
PubMed
Close
,
E. TohidiInstitute of Public Health Research, Teheran University, Teheran, Iran

Search for other papers by E. Tohidi in
Current site
Google Scholar
PubMed
Close
, and
A. ArdelanInstitute of Public Health Research, Teheran University, Teheran, Iran

Search for other papers by A. Ardelan in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

A slow method of administering sodium antimony dimercaptosuccinate was tried in 163 cases of haematobium bilharziasis in an effort to reduce side-effects. The drug was given over a period of 2½ weeks, the total amount being the same as tried previously in a short 5-day administration schedule.

The severity and number of side-effects were the same in both trials. However, the data suggest that the parasitologic rate of cure is reduced from 100% in the short schedule to 80% in the slow one.

Author Notes

Associate Professor, Institute of Public Health Research.

Epidemiologist, Institute of Public Health Research.

Senior Field Technician, Institute of Public Health Research.

Save